FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/13/2025
Back to search
Official data from USPTO
RIGENASIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RIGENASIDE
ST13
US500000079373811Class
3, 5, 10
Filing
79373811
Registration
7602060
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/03/2026
Trademark type
Word
Nice classes
3, 5, 10
Filing date
04/05/2023
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IT
Examiner
GOODWIN, KATRINA JOYE
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
FARMACEUTICI DAMOR S.P.A.
Representatives
Ben Natter HAUG PARTNERS, LLP
Technical classification
Nice Classes
Class 3Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetic creams; cosmetic barrier creams; skin care preparationsother than for medical purposes; non-medicated creams for stretch marks and cellulite blemishes; cosmetic firming and slimming creams; anti-aging creams; anti-wrinkle creams; creams for skin spotsother than for medical purposes; non-medicated face and body exfoliant creams and moisturizers; massage creams and oils; beauty masks; non-medicated face and body soaps and gels; non-medicated skin care creams; soaps and intimate hygiene preparationsother than for medical purposes; cosmetic preparations for tanning the skin and sunscreen preparations; nail care preparationsother than for medical purposes; nail varnish; body cleaning preparations; deodorants and antiperspirants; make-up preparations and make-up removers; foundation and face make-up; non-medicated hair and bath preparations and treatments; hair removal and shaving preparations; non-medicated sanitary preparations being toiletries; perfumery; fragrances; essential oils and bath oils for use in aroma therapy; non-medicated oral hygiene preparations
Class 5
Pharmaceutical preparations for the treatment of dermatological diseases and disorders; natural remedies for the treatment of dermatological diseases and disorders in the nature of wheat-based preparations; pharmaceutical products for gynecological usetherapeutic topical creams for the treatment of gynecological diseases and disorders; medical preparations for dermatological use; pharmaceutical creamsmedicated lip creamscreams for dermatological use; medicinal creams for skin care; protective creams for dermatological use; topical analgesic creams; medicated creams and medical preparations for treatment of scarsskin blemishesdermatitis and psoriasis; medicinal creams and medicated preparations for intimate hygiene; dressingsmedical; sterilized dressing; disinfectants and antiseptics; bandages and plasters for skin wounds; cotton for medical purposes; sanitary preparations for medical use; medicinal mud; bath preparations for medical purposes; nutritional supplements and dietary supplements for human use; pre-filled syringes for medical purposessyringes sold filled with pharmaceutical preparations for the treatment of dermatological diseases and conditions; gauze for dressings
Class 10
Syringes for medical purposes; disposable syringes; syringes for injections; vaginal syringes; hypodermic syringes; applicators for pharmaceutical preparations in the nature of syringes; apparatus for administering intravenous solutions in the nature of syringes; intravenous administration instruments for medical purposes in the nature of syringes; devices for injecting pharmaceuticals in the nature of syringes; apparatus for administering pharmaceuticals in the nature of syringes; medical apparatus and instruments for use in the removal of blemishes in subjects with signs of skin aging; therapeutic facial masks; apparatusdevices and instruments used in aesthetic medicine and dermatology treatments in the nature of medical devices to remove blemishes in subjects with signs of skin aging; apparatusdevices and instruments used in curative cosmetics in the nature of facial toning machines for cosmetic use; medical equipmentdevices and instruments used in cosmetics in the nature of medical devices for nonsurgical cosmetic treatments; injectors for medical purposes; surgical implants comprised of artificial material; esthetic massage apparatus; apparatus for acne treatment
Publications
History of USPTO decisions and trademark events.
42 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/23/2025
FIMP
FINAL DISPOSITION PROCESSED
05/23/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/28/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/11/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/26/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
07/26/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/26/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
07/26/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/26/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/24/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/01/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/14/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/13/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/12/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/23/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/23/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/23/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/23/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/23/2024
GRML
CORRESPONDENCE E-MAILED
05/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/23/2024
RFNT
REFUSAL PROCESSED BY IB
02/14/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/25/2024
RFRR
REFUSAL PROCESSED BY MPU
01/25/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/10/2024
CNRT
NON-FINAL ACTION WRITTEN
01/09/2024
DOCK
ASSIGNED TO EXAMINER
01/02/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/16/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/13/2023
Continuous trademark protection
Get notified about every new filing that threatens RIGENASIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.